Asia’s IPO Market Set for Strong Growth as China and India Drive Investor Diversification 
IKEA Launches First New Zealand Store, Marking Expansion Into Its 64th Global Market 
Firelight Launches as First XRP Staking Platform on Flare, Introduces DeFi Cover Feature 
U.S. Futures Steady as Rate-Cut Bets Rise on Soft Labor Data 
European Stocks Rise as Markets Await Key U.S. Inflation Data 
Hikvision Challenges FCC Rule Tightening Restrictions on Chinese Telecom Equipment 
China’s Services Sector Posts Slowest Growth in Five Months as Demand Softens 
Michael Dell Pledges $6.25 Billion to Boost Children’s Investment Accounts Under Trump Initiative 
Sam Altman Reportedly Explored Funding for Rocket Venture in Potential Challenge to SpaceX 
Australia Moves Forward With Teen Social Media Ban as Platforms Begin Lockouts 
Dollar Weakens Ahead of Expected Federal Reserve Rate Cut 
ExxonMobil to Shut Older Singapore Steam Cracker Amid Global Petrochemical Downturn 
Momenta Quietly Moves Toward Hong Kong IPO Amid Rising China-U.S. Tensions 
Europe Confronts Rising Competitive Pressure as China Accelerates Export-Led Growth 
Airbus Faces Pressure After November Deliveries Dip Amid Industrial Setback 
BOJ Governor Ueda Highlights Uncertainty Over Future Interest Rate Hikes 
Airline Loyalty Programs Face New Uncertainty as Visa–Mastercard Fee Settlement Evolves 
Roche will be making big changes in the organization of its employees, which is estimated to be around 100,000 in number. The company is taking this step as it implements new prioritization of the works.
Announcement of change in the workforce
As part of the plans, Roche will be eliminating 300 to 400 jobs this year. The affected employees will be the ones working at the company’s product development sites.
According to Reuters, the news about job cuts was announced by Levi Garraway, the firm’s chief medical officer. Through a video call with the employees, he directly told them what the company is planning to do.
"We have made the difficult decision to reduce our workforce in PD by around five to seven percent by the end of the year," he said. "And that equates to somewhere between 300 to 400 roles that will be impacted globally."
The company knows that this is a big blow to the affected workers, so Roche will try to lessen the impact by working with employees. It was not mentioned, though, how the company intends to help those who are about to lose their position.
Who are set to lose their jobs
Based on the information shared, the Roche employees that will be cut from the company are those who are in the product development units and working in the area of project management, business management, administrative support, project delivery, managers, and posts in learning and development.
The product development sites that will cut workers are located in Canada, Britain, United States, Switzerland, and China. Those who will be laid off are set to be notified between the months of August and October, and British employees are the first ones to go.
Felix Arellano, Roche’s head of global drug safety, admitted that this is the hardest thing that he had to do since he started working for the company. He was referring to the fact that he has to send off colleagues as they have been eliminated by the company, as per Fierce Biotech.
Finally, while Roche is cutting jobs, some of the other major pharmaceutical companies are looking for more workers. Most are building new factories, so they need to hire hundreds of workers.
